Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis

Cardiovasc Drugs Ther. 2024 Jun;38(3):527-538. doi: 10.1007/s10557-023-07428-1. Epub 2023 Jan 18.

Abstract

Purpose: Activation of mitogen-activated protein kinases (MAPKs) by pathological stimuli participates in cardiovascular diseases. Dysfunction of adventitial fibroblast has emerged as a critical regulator in vascular remodeling, while the potential mechanism remains unclear. In this study, we sought to determine the effect of different activation of MAPKs in adventitial fibroblast contributing to neointima formation.

Methods: Balloon injury procedure was performed in male 12-week-old Sprague-Dawley rats. After injury, MAPK inhibitors were applied to the adventitia of injured arteries to suppress MAPK activation. Adventitial fibroblasts were stimulated by platelet-derived growth factor-BB (PDGF-BB) with or without MAPK inhibitors. RNA sequencing was performed to investigate the change of pathway and cell function. Wound healing, transwell assay, and flow cytometry were used to analyze adventitial fibroblast function.

Results: Phosphorylation of p38, c-Jun N-terminal kinase (JNK), and extracellular regulated kinases 1/2 (ERK1/2) was increased in injured arteries after balloon injury. In primary culture of adventitial fibroblasts, PDGF-BB increased phosphorylation of p38, JNK, ERK1/2, and extracellular regulated kinase 5 (ERK5) in a short time, which was normalized by their inhibitors respectively. Compared with the injury group, perivascular administration of four MAPK inhibitors significantly attenuated neointima formation by quantitative analysis of neointimal area, intima to media (I/M) ratio, and lumen area. RNA sequencing of adventitial fibroblasts treated with PDGF-BB with or without four inhibitors demonstrated differentially expressed genes involved in multiple biological processes, including cell adhesion, proliferation, migration, and inflammatory response. Wound healing and transwell assays showed that four inhibitors suppressed PDGF-BB-induced adventitial fibroblast migration. Cell cycle analysis by flow cytometry demonstrated that JNK, ERK1/2, and ERK5 but not p38 inhibitor blocked PDGF-BB-induced G1 phase release associated with decrease expression of cell cycle protein Cyclin D1 and transcription factor GATA4. Moreover, four inhibitors decreased macrophage infiltration into adventitia and monocyte chemoattractant protein-1 (MCP-1) expression.

Conclusion: These results suggest that MAPKs differentially regulate activation of adventitial fibroblast through GATA4/Cyclin D1 axis that participates in neointima formation.

Keywords: Adventitia; Cyclin D1; GATA4; Inflammation; MAPKs; Neointima formation.

MeSH terms

  • Adventitia* / drug effects
  • Adventitia* / enzymology
  • Adventitia* / metabolism
  • Adventitia* / pathology
  • Angioplasty, Balloon / adverse effects
  • Animals
  • Becaplermin* / pharmacology
  • Carotid Artery Injuries / drug therapy
  • Carotid Artery Injuries / enzymology
  • Carotid Artery Injuries / metabolism
  • Carotid Artery Injuries / pathology
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cyclin D1* / genetics
  • Cyclin D1* / metabolism
  • Disease Models, Animal
  • Fibroblasts* / drug effects
  • Fibroblasts* / enzymology
  • Fibroblasts* / metabolism
  • Fibroblasts* / pathology
  • Male
  • Mitogen-Activated Protein Kinases* / metabolism
  • Neointima*
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley*
  • Signal Transduction
  • Vascular System Injuries / drug therapy
  • Vascular System Injuries / enzymology
  • Vascular System Injuries / metabolism
  • Vascular System Injuries / pathology